Eton stockholders elect director Paul V. Maier; ratify Crowe LLP as auditor

Eton Pharmaceuticals, Inc.

Paul V. Maier elected as director for three-year term with 11.67M votes for, 2.74M against.
Ratification of Crowe LLP as independent auditor for 2025 approved with 18.89M for, 0.15M against.
Votes reflect standard annual meeting procedural items; no material operational changes.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.